
|Videos|July 27, 2016
ACO Growth Impact on Specialty Pharmacy
Author(s)Lauren Santye, Assistant Editor
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses the impact of Accountable Care Organizations on specialty pharmacy.
Advertisement
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses the impact of Accountable Care Organizations on specialty pharmacy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Low-Dose Cannabinoids Show Potential to Restore Serotonin Levels and Reduce Inflammation in HIV, Study Finds
2
FDA Approves New Dosing Strength of Xolair Biosimilar, Omlyclo
3
MRD, ctDNA Testing May Help Diagnose Multiple Myeloma Precursor Conditions
4
Pharmacists Can Advance Lung Cancer Screening Awareness in High-Risk Patients
5


















































































































































































































